Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Nafronyl oxalate |
EINECS | 221-703-0 |
CAS No. | 3200-06-4 | Density | 1.2205 (rough estimate) |
PSA | 113.37000 | LogP | 3.60820 |
Solubility | N/A | Melting Point |
110-111° |
Formula | C24H33NO3.C2H2O4 | Boiling Point | 664.4°C at 760 mmHg |
Molecular Weight | 473.566 | Flash Point | 355.6°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion and subcutaneous routes. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx. | Risk Codes | R22 |
Molecular Structure | Hazard Symbols | ||
Synonyms |
Naftidrofuryl oxalate; alpha-(1-Naphthylmethyl)-2-tetrahydrofuranpropionic acid diethylaminoethyl ester oxalate |
Article Data | 2 |
Conditions | Yield |
---|---|
In water; acetone for 1h; Reflux; | 80% |
Product Name: Nafronyl oxalate (CAS NO.3200-06-4)
Molecular Formula: C26H35NO7
Molecular Weight: 473.56g/mol
Mol File: 221-703-0.mol
H-Bond Donor: 2
H-Bond Acceptor: 8
Structure Descriptors of Nafronyl oxalate (CAS NO.3200-06-4):
IUPAC Name: 2-diethylaminoethyl 2-(naphthalen-1-ylmethyl)-3-(oxolan-2-yl)propanoate;oxalic acid
Canonical SMILES: CCN(CC)CCOC(=O)C(CC1CCCO1)CC2=CC=CC3=CC=CC=C32.C(=O)(C(=O)O)O
InChI: InChI=1S/C24H33NO3.C2H2O4/c1-3-25(4-2)14-16-28-24(26)21(18-22-12-8-15-27-22)17-20-11-7-10-19-9-5-6-13-23(19)20;3-1(4)2(5)6/h5-7,9-11,13,21-22H,3-4,8,12,14-18H2,1-2H3;(H,3,4)(H,5,6)
InChIKey: SSAJNPNVUYMUCI-UHFFFAOYSA-N
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LDLo | intravenous | 71mg/kg (71mg/kg) | Chimica Therapeutica. Vol. 3, Pg. 463, 1968. | |
mouse | LD50 | intramuscular | 696mg/kg (696mg/kg) | Chimica Therapeutica. Vol. 3, Pg. 463, 1968. | |
mouse | LD50 | intraperitoneal | 159mg/kg (159mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: CYANOSIS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14, Pg. 1237, 1986. |
mouse | LD50 | intravenous | 18400ug/kg (18.4mg/kg) | United States Patent Document. Vol. #4439442, | |
mouse | LD50 | oral | 365mg/kg (365mg/kg) | United States Patent Document. Vol. #4652583, | |
mouse | LD50 | subcutaneous | 547mg/kg (547mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14, Pg. 1237, 1986. |
rabbit | LDLo | intravenous | 8mg/kg (8mg/kg) | AUTONOMIC NERVOUS SYSTEM: "SMOOTH MUSCLE RELAXANT (MECHANISM UNDEFINED, SPASMOLYTIC)" LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. Vol. 11, Pg. 103, 1985. |
rabbit | LDLo | oral | 1gm/kg (1000mg/kg) | GASTROINTESTINAL: ULCERATION OR BLEEDING FROM STOMACH | Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. Vol. 11, Pg. 81, 1985. |
rat | LD50 | intraperitoneal | 98mg/kg (98mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14, Pg. 1237, 1986. |
rat | LD50 | intravenous | 11080ug/kg (11.08mg/kg) | United States Patent Document. Vol. #4439442, | |
rat | LD50 | oral | 711mg/kg (711mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14, Pg. 1237, 1986. |
rat | LD50 | subcutaneous | 896mg/kg (896mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14, Pg. 1237, 1986. |
Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion and subcutaneous routes. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx.
Safety Information of Nafronyl oxalate (CAS NO.3200-06-4):
Hazard Codes: Xn,Xi
Risk Statements: 22
22: Harmful if swallowed
Safety Statements: 36
36: Wear suitable protective clothing .
Nafronyl oxalate ,its CAS NO. is 3200-06-4,the synonyms is Diethyl(2-(2-(1-naphthylmethyl)-3-(tetrahydro-2-furyl)propionyloxy)ethyl)ammonium hydrogen oxalate ; 2-(Diethylamino)ethyl tetrahydro-alpha-(1-naphthylmethyl)-2-furanpropionate oxalate (1:1) ; Dubimax ; Dusodril ; EINECS 221-703-0 ; EU-1806 ; Gevatran ; Iridus ; LS 121 ; NSC 225233 ; Naftidrofuryl oxalate ; Naphtidrofuryl oxalate ; Praxilene ; UNII-5ADB8D9388 .